Clinical trials
Gout trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 11 |
| Not yet recruiting | 6 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lille Catholic University | 5 |
| University of Alabama at Birmingham | 4 |
| Diakonhjemmet Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Sheffield Hallam University | 2 |
| SingHealth Polyclinics | 2 |
| University of Edinburgh | 2 |
| University of South Carolina | 2 |
| VA Office of Research and Development | 2 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gout | 57 |
| Hyperuricemia | 10 |
| Arthritis | 8 |
| Arthritis, Rheumatoid | 4 |
| Cardiovascular Diseases | 4 |
| Lupus Erythematosus, Systemic | 4 |
| Diabetes Mellitus | 3 |
| Fibromyalgia | 3 |
| Obesity | 3 |
| Osteoarthritis | 3 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.